Readoutin 14d
Cloudbreak Therapeutics, LLC — CBT-001
Phase 3 primary completion: Safety and efficacy of CBT-001 in patients with pterygium.
- Date
- Dec 2026
- Type
- Readout
- Indication
- Pterygium
Readoutin 14d
Phase 3 primary completion: Safety and efficacy of CBT-001 in patients with pterygium.
The weekly brief is free. Pro adds reminders 7 days and 1 day before.